First food: business of taste
Good Food is First Food. It is not junk food. It is the food that connects nature and nutrition with livelihoods. This food is good for our health; it comes from the rich biodiversity of our regions; it
Good Food is First Food. It is not junk food. It is the food that connects nature and nutrition with livelihoods. This food is good for our health; it comes from the rich biodiversity of our regions; it
After complaints that private nursing homes and hospitals had refused to admit dengue patients, Delhi government's health department and the Municipal Corporation of Delhi (MCD) has decided to
A high alert has been sounded against dengue in Ghaziabad, Bagpat, Bulandshahar, Noida, Muzaffarnagar, Bijnore and Meerut districts where 1,012 patients have been registered so far. Meanwhile,
A recent study conducted by the WHO shows that in the present year there are an estimated 135 million diabetes mellitus patients in the world, and this number is expected to increase to 300 million
Researchers at the University of Massachusetts say they have discovered a promising strategy for arresting future epidemics of severe acute respiratory syndrome
An ambitious plan by the World Health Organisation to raise $200 million from companies and governments to strengthen public-health infrastructure in China and elsewhere has fallen massively short of
the one day summit titled
The government has rejected claims made in the Supreme Court that many essential drugs are not included in the national list of essential medicines under the controversial pharmaceutical policy of
Britain and Germany are to work closely on modernising their health sectors, including on controversial British government plans to allow some hospitals to operate more independently of the National
Worm-infested Cadbury chocolates continue to pop up in Maharashtra. The latest sighting was in a departmental store owned by former minister Shrikant Jichkar. Another batch of worm-infested
With the Government yet to take a call on allowing Phase I clinical trials in India, Ranbaxy looks poised to take the human trial for its investigational new drug (IND) in the benign prostrate